LETITIA L ANDERSON
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease SPARKS, NV NPI 1700946019
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease NV NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$1,343.46
- Category: General Payments
- Program years: PY2019–2024
- Record count: 45
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $127.90 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $127.90 | 6 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $65.43 | 3 |
| Merck Sharp & Dohme Corporation | $23.60 | 1 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $21.91 | 1 |
| Acerta Pharma LLC | $16.96 | 1 |
By program year
Records — PY2024 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1080649907 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $21.91 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086705097 | Novartis Pharmaceuticals Corporation | $15.57 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086705115 | Novartis Pharmaceuticals Corporation | $28.57 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086705117 | Novartis Pharmaceuticals Corporation | $21.29 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105516773 | AstraZeneca Pharmaceuticals LP | $16.96 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141611598 | Merck Sharp & Dohme LLC | $23.60 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.